Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patrizia Silvi is active.

Publication


Featured researches published by Patrizia Silvi.


Respiratory Medicine | 2016

Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study

Sara Maio; Sandra Baldacci; Laura Carrozzi; Francesco Pistelli; Anna Angino; Marzia Simoni; Giuseppe Sarno; Sonia Cerrai; Franca Martini; Martina Fresta; Patrizia Silvi; Francesco Di Pede; Massimo Guerriero; Giovanni Viegi

BACKGROUND Few epidemiological surveys on general population samples estimated changes in prevalence of respiratory symptoms/diseases over a long time interval; our study aims to quantify the temporal changes in the prevalence rates of asthma, allergic rhinitis and Chronic Obstructive Pulmonary Disease (COPD) after 25 years from baseline. METHODS A general population sample participated in 3 cross-sectional surveys carried out in Central Italy (Pisa) in 1985-88 (n = 3865), 1991-93 (n = 2841), 2009-11 (n = 1620). 2276 (47%) subjects participated in at least 1 survey, 1723 (35.5%) in at least 2 surveys and 849 (17.5%) in all the 3 surveys. All subjects filled in a standardized questionnaire about health status and risk factors; a sub-sample performed spirometry. Chi-square test was used to compare adjusted prevalence rates of respiratory symptoms/diseases and descriptive characteristics among the surveys. Generalised estimating equations (GEE) were used to analyze the association between respiratory symptoms/diseases and risk factors. RESULTS There was an increasing trend in prevalence rates of all respiratory symptoms/diseases throughout the surveys: current asthma attacks (1st-3rd survey prevalence: 3.4-7.2%), allergic rhinitis (16.2-37.4%), usual phlegm (8.7-19.5%) and COPD (2.1-6.8%) more than doubled. The GEE model confirmed these increasing trends, indicating higher risk of having respiratory symptoms/diseases in the second and third surveys. CONCLUSIONS While asthma and allergic rhinitis increasing trends were confirmed, with respect to other international studies, also a COPD increasing prevalence rates was shown.


European Respiratory Journal | 2015

COPD symptoms/diagnoses and work exposure: A 20 years population-based survey

Giuseppe Sarno; Sonia Cerrai; Sandra Baldacci; Sara Maio; Marzia Simoni; Franca Martini; Patrizia Silvi; Anna Angino; Martina Fresta; Francesco Di Pede; Francesco Pistelli; Laura Carrozzi; Giovanni Viegi

Background: work exposure to fumes/gases/chemicals is associated with COPD symptoms/diagnosis but few epidemiological surveys on general population samples estimated such relationship over a long time interval. Objectives: to assess the association between long term work exposure to fume/gas/chemicals and COPD symptoms/diagnosis over a 20 yrs period. Methods: a general population sample participated in 2 surveys carried out in Pisa in 1991-93 and 2009-11. A standardised questionnaire on health status and risk factors was used. Chi-square test was used to compare long term work exposure [ever exposed (EE), at least once exposed (ATOE), never exposed (NE)] and the change in COPD symptoms/diagnosis from the 1st to the 2nd survey (COPD symptoms: persistent/incident vs never/remittent; COPD diagnosis: persistent/incident vs never/remittent). Logistic regression models (LRM) were run to analyse the association between persistent/incident COPD symptoms/diagnosis and work exposure adjusted for gender, age, smoking habits, asthma symptoms/diagnosis at the 1st survey, smoking habits and lifetime passive smoke exposure. Results: there were 1107 longitudinal subjects: 27.5% EE, 30.4% ATOE and 42.1% NE. LRM showed a significantly higher risk of having persistence/onset of: COPD diagnosis (OR=2.4, 95%CI=1.4-3.9), dyspnoea (OR=2.0, 95%CI=1.4-2.9), usual phlegm (OR=2.2, 95%CI=1.5-3.3), usual cough (OR= 1.6, 95%CI=1.0-2.3), in EE; dyspnoea (OR=1.7, 95%CI=1.2-2.3), usual phlegm (OR=1.5, 95%CI=1.1-2.2) in ATOE. Conclusions: our findings indicate a longitudinal association between work exposure and COPD. There is a need for the EU to implement effective strategies for COPD prevention in work settings.


European Respiratory Journal | 2015

Odor annoyance perception and health effects in an Italian general population sample

Sandra Baldacci; Sara Maio; Franca Martini; Patrizia Silvi; Giuseppe Sarno; Sonia Cerrai; Anna Angino; Martina Fresta; Giovanni Viegi

Background: Recently, there has been a growing interest about the emission of unpleasant odors due to their potential health impacts. Aim: to evaluate the associations between odor annoyance perception and health in neighbors of Pisa waste incinerator. Methods: the circular study area, centered on the incinerator, was divided in 5 rings, with radius 0.4, 0.8, 1.4, 2.7, 4.0, for sampling subjects according to household residence. Controls were randomly chosen outside the study area. 1407 subjects filled out a self-administered standardized questionnaire on respiratory symptoms/diseases, cancer, cardiovascular diseases, risk factors and odor annoyance levels (no, slightly annoying, very annoying). Results: prevalence rates of odor annoyance perception in 1407 subjects participating in the survey (50% males, mean age 44 ± 22 yrs) were: 39.8% no odor perceived;19.1% slightly annoying odors; 41.2% very annoying odors. By multivariate analysis, adjusted for independent effects ofgender, age, residence-incinerator distance, education, working position, active and passive smoking, residence duration, occupational exposure, odor annoyance perception was significantly associated with the following respiratory symptoms/diseases: phlegm (OR 2.13, 95%CI 1.40-3.23), cough (OR 2.54, 95%CI 1.74-3.71), Chronic Obstructive Pulmonary Disease (OR 1.88, 95%CI 1.01-3.48), dyspnea (OR 1.89, 95%CI 1.33-2.67), asthma (OR 1.95, 95%CI 1.14-3.35), asthma symptoms (OR 1.85, 95%CI 1.23-2.78) and allergic rhinitis (OR 1.53, 95%CI 1.05-2.24). Conclusion: Our study shows an association among respiratory effects and odor annoyance perception, which thus might be used as a proxy of environmental air pollution exposure.


Respiratory Medicine | 2012

The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management

Sandra Baldacci; Sara Maio; Marzia Simoni; Sonia Cerrai; Giuseppe Sarno; Patrizia Silvi; Francesco Di Pede; Marco Borbotti; Anna Paola Pala; Megon Bresciani; Giovanni Viegi


Archive | 2018

AIS LIFE project: pollen allergy risk maps in Tuscany

Francesca Natali; Marco Napoli; Anna Dalla Marta; Giovanni Argenti; Lorenzo Cecchi; Simone Orlandini; Sandra Baldacci; Anna Angino; Patrizia Silvi; Stefania La Grutta; Sara Maio; Giovanni Viegi; Franco Ruggiero; Gianni Bedini; Uwe Berger; Marija Prentovic; Isabella Annesi Maesano; Amir Moustafa; Michel Thibaudon; Samuel Monnier


ATTI DELLA SOCIETÀ TOSCANA DI SCIENZE NATURALI RESIDENTE IN PISA. MEMORIE. SERIE B | 2018

The AIS LIFE project: the Italian enrollment phase results

Sandra Baldacci; Sara Maio; Anna Angino; Patrizia Silvi; Marzia Simoni; Stefania La Grutta; Giovanni Viegi; Franco Ruggiero; Gianni Bedini; Francesca Natali; Lorenzo Cecchi; Uwe Berger; Marija Prentovic; Isabella Annesi-Maesano; Amir Moustafa; Michel Thibaudon; Samuel Monnier; Simone Orlandini


European Respiratory Journal | 2015

Effect of not appropriate treatment in severe/not controlled asthma: The AGAVE study

Sara Maio; Sandra Baldacci; Franca Martini; Patrizia Silvi; Giuseppe Sarno; Sonia Cerrai; Anna Angino; Anna Paola Pala; Giovanni Viegi


110° Congresso della Società Botanica Italiana, II INTERNATIONAL PLANT SCIENCE CONFERENCE (IPSC) “NOT ONLY FOOD: SUSTAINABLE DEVELOPMENT, AGRO-BIODIVERSITY CONSERVATION & HUMAN WELL BEING” | 2015

AIS LIFE – AEROBIOLOGICAL INFORMATION SYSTEM AND ALLERGIC RESPIRATORY DISEASE MANAGEMENT - LIFE13ENV/IT/001107

Franco Ruggiero; Simone Orlandini; Francesca Natali; Lorenzo Cecchi; Sandra Baldacci; Sara Maio; Giuseppe Sarno; Sonia Cerrai; Patrizia Silvi; Uwe Berger; Marija Prentovic; Isabella Annesi Maesano; Amir Moustafa; Michel Thibaudon; Samuel Monnier; Gilles Oliver; Gianni Bedini


XV Congresso Nazionale della Pneumologia FIP/SIMeR | 2014

Abitudini al fumo e sintomi/diagnosi di BPCO in un campione di popolazione generale monitorato per 25 anni

Giuseppe Sarno; Sara Maio; S. Baldacci; Franca Martini; Patrizia Silvi; Sonia Cerrai; Anna Angino; Martina Fresta; F Di Pede; F Pistelli; Laura Carrozzi; G. Viegi


RASSEGNA DI PATOLOGIA DELL’APPARATO RESPIRATORIO | 2014

Mortalità per malattie respiratorie in Italia (1990-2010). Parte II: Tassi standardizzati, confronto con l’Europa e conclusioni.

Marzia Simoni; Sandra Baldacci; Sara Maio; Sonia Cerrai; Giuseppe Sarno; Patrizia Silvi; Laura Carrozzi; Francesco Pistelli; Giovanni Viegi

Collaboration


Dive into the Patrizia Silvi's collaboration.

Top Co-Authors

Avatar

Sara Maio

National Research Council

View shared research outputs
Top Co-Authors

Avatar

Giovanni Viegi

National Research Council

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Sarno

National Research Council

View shared research outputs
Top Co-Authors

Avatar

Sonia Cerrai

National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna Angino

National Research Council

View shared research outputs
Top Co-Authors

Avatar

Franca Martini

National Research Council

View shared research outputs
Top Co-Authors

Avatar

Marzia Simoni

National Research Council

View shared research outputs
Top Co-Authors

Avatar

Marco Borbotti

National Research Council

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge